Pronto Diagnostics Plans to Integrate FDNA’s Phenotypic Analysis Into Its Genetic Tests

March 1, 2018

Pronto Diagnostics

“The Israeli molecular diagnostics company will use artificial intelligence and phenotypic analysis to increase the diagnostic rate of its genetic tests.”

 

The article discusses Pronto Diagnostics’ plans to incorporate FDNA’s phenotypic analysis technology into its genetic tests. By leveraging FDNA’s advanced facial recognition capabilities, Pronto aims to enhance the accuracy and efficiency of genetic diagnostics. FDNA’s system uses artificial intelligence to analyze facial features, identifying subtle phenotypic markers associated with various genetic conditions. This integration promises to refine diagnostic processes, making it easier to pinpoint genetic disorders that might be overlooked by traditional methods. The collaboration highlights the growing importance of combining genetic tests with phenotypic data to improve patient outcomes and advance personalized medicine.

Read More

Share this article

Most popular news

Related articles

Dr. Bruno

The Importance of Teaching Face2Gene to Pediatricians

In the world of rare genetic diseases, early diagnosis is often the key to better patient outcomes. However, the diagnostic journey can be long and complex, sometimes taking years before a definitive answer is found. Dr. Bruno Bordest, a Brazilian geneticist who teaches at the Universidade Federal de Mato Grosso, has been working to bridge […]

Continue reading
AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading